GlassScriptPhysician profile
Stephen G Hiuga
NPI 1467428789
$2,465.13
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $861 · 2020: $286 · 2021: $475 · 2022: $416 · 2023: $323 · 2024: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $497.10 | 2019-2024 | |
| Coopersurgical, INC. | $429.14 | 2019-2022 | |
| Hologic Sales and Service, LLC | $258.13 | 2019-2024 | Aptima |
| Therapeuticsmd, INC. | $223.96 | 2019-2022 | |
| Allergan, INC. | $196.15 | 2019-2020 | |
| Astellas Pharma US INC | $116.54 | 2023 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $102.90 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $71.46 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $70.89 | 2022-2023 | |
| Sage Therapeutics, LLC | $67.37 | 2021-2023 | |
| Lupin INC. | $67.30 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $54.11 | 2019-2020 | |
| Roche Diagnostics Corporation | $50.23 | 2019 | |
| Organon LLC | $44.87 | 2021-2023 | Nexplanon |
| Aspira Women'S Health INC | $37.59 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $31.39 | 2021-2022 | |
| Medtronic, INC. | $23.45 | 2022 | |
| Verrica Pharmaceuticals INC. | $22.95 | 2024 | Ycanth |
| Exeltis, USA INC. | $22.76 | 2020 | |
| Ascend Therapeutics US, LLC | $21.85 | 2023 | |
| Sumitomo Pharma America, INC. | $21.77 | 2023 | Myfembree |
| Vertical Pharmaceuticals, LLC | $17.30 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hiuga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.